quinazolines has been researched along with Nephrotic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bou Matar, RN; Klein, JD; Sands, JM | 1 |
| COOKE, AR | 1 |
| DEAN, H; DEVRIES, A; LIEBERMANN, A; PINKHAS, J | 1 |
| Hasegawa, Y; Kumasaka, R; Nakamura, M; Nakamura, N; Okumura, K; Osawa, H; Shirato, K; Takanashi, S; Tamura, M; Yamabe, H | 1 |
4 other study(ies) available for quinazolines and Nephrotic Syndrome
| Article | Year |
|---|---|
Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
Topics: Animals; Antibiotics, Antineoplastic; Aquaporin 2; Creatinine; Doxorubicin; Epithelial Sodium Channels; ErbB Receptors; Erlotinib Hydrochloride; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Male; Nephrotic Syndrome; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Rats; Renal Insufficiency; Sodium Chloride Symporters; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1 | 2013 |
A CLINICAL TRIAL OF A NEW QUINAZOLINONE DIURETIC.
Topics: Coronary Disease; Diuretics; Edema; Humans; Liver Cirrhosis; Nephrotic Syndrome; Organomercury Compounds; Quinazolines; Quinazolinones; Sulfonamides | 1964 |
[THE TREATMENT OF NEPHROTIC SYNDROME].
Topics: Humans; Nephrotic Syndrome; Quinazolines; Sulfonamides; Therapeutics | 1964 |
Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.
Topics: Aged; Gefitinib; Humans; Lung Neoplasms; Male; Neoplasms, Squamous Cell; Nephrotic Syndrome; Quinazolines | 2004 |